Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pilar Escribano

Showing results (191-200 of 270) with videos related to

Pageof 27
Sort By:
Heart (British Cardiac Society)|October 30, 2023
Triple vasodilator therapy in pulmonary arterial hypertension associated with congenital heart diseaseRaquel Luna-Lopez, Teresa Segura de la Cal, Fernando Sarnago Cebada, et al.
Revista Espanola De Cardiologia|March 8, 2003
[Ten years' experience in continuous intravenous epoprostenol therapy in severe pulmonary arterial hypertension]Marta Pombo Jiménez, Pilar Escribano Subías, Rocío Tello de Meneses, et al.
Archivos De Bronconeumologia|May 24, 2011
[Respiratory disease registries in Spain: fundamentals and organization]Beatriz Lara, Pilar Morales, Ignacio Blanco, et al.
International Journal of Cardiology|October 15, 2018
Real-life experience of inhaled iloprost for patients with pulmonary arterial hypertension: Insights from the Spanish REHAP registryRoberto Del Pozo, Isabel Blanco, Ignacio Hernández-González, et al.
Medicina Clinica|February 25, 2017
Pulmonary endarterectomy outputs in chronic thromboembolic pulmonary hypertensionMaría Jesús López Gude, Enrique Pérez de la Sota, Jose Luís Pérez Vela, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 20, 2021
Detection of azole resistance in Aspergillus fumigatus complex isolates using MALDI-TOF mass spectrometryMargarita Estreya Zvezdanova, Manuel J Arroyo, Gema Méndez, et al.
Rheumatology (Oxford, England)|February 27, 2026
New phenotype and outcomes in connective tissue disease-associated pulmonary arterial hypertension: relevance of age-related comorbiditiesRafael Bravo-Marqués, Francisco Rivas-Ruiz, Andrés Tenes, et al.
International Journal of Cardiology|March 18, 2015
Pulmonary hypertension and congenital heart disease: An insight from the REHAP National RegistryRafael Alonso-Gonzalez, Carmen Jiménez Lopez-Guarch, Maria Teresa Subirana-Domenech, et al.
International Journal of Cardiology|February 13, 2017
Benefits of skeletal-muscle exercise training in pulmonary arterial hypertension: The WHOLEi+12 trialLaura González-Saiz, Carmen Fiuza-Luces, Fabian Sanchis-Gomar, et al.
Open Forum Infectious Diseases|July 14, 2026
Evaluation of Quantitative Differences of Classic Methods, Fungal Biomarkers, and T2Candida for Assessing the Central Venous Catheter Origin of CandidemiaAna Soriano-Martín, Antonio Vena, María Jesús Pérez-Granda, et al.
Pageof 27

Showing results (191-200 of 270) with videos related to

Sort By:
Pageof 27
Heart (British Cardiac Society)|October 30, 2023
Triple vasodilator therapy in pulmonary arterial hypertension associated with congenital heart diseaseRaquel Luna-Lopez, Teresa Segura de la Cal, Fernando Sarnago Cebada, et al.
Revista Espanola De Cardiologia|March 8, 2003
[Ten years' experience in continuous intravenous epoprostenol therapy in severe pulmonary arterial hypertension]Marta Pombo Jiménez, Pilar Escribano Subías, Rocío Tello de Meneses, et al.
Archivos De Bronconeumologia|May 24, 2011
[Respiratory disease registries in Spain: fundamentals and organization]Beatriz Lara, Pilar Morales, Ignacio Blanco, et al.
International Journal of Cardiology|October 15, 2018
Real-life experience of inhaled iloprost for patients with pulmonary arterial hypertension: Insights from the Spanish REHAP registryRoberto Del Pozo, Isabel Blanco, Ignacio Hernández-González, et al.
Medicina Clinica|February 25, 2017
Pulmonary endarterectomy outputs in chronic thromboembolic pulmonary hypertensionMaría Jesús López Gude, Enrique Pérez de la Sota, Jose Luís Pérez Vela, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 20, 2021
Detection of azole resistance in Aspergillus fumigatus complex isolates using MALDI-TOF mass spectrometryMargarita Estreya Zvezdanova, Manuel J Arroyo, Gema Méndez, et al.
Rheumatology (Oxford, England)|February 27, 2026
New phenotype and outcomes in connective tissue disease-associated pulmonary arterial hypertension: relevance of age-related comorbiditiesRafael Bravo-Marqués, Francisco Rivas-Ruiz, Andrés Tenes, et al.
International Journal of Cardiology|March 18, 2015
Pulmonary hypertension and congenital heart disease: An insight from the REHAP National RegistryRafael Alonso-Gonzalez, Carmen Jiménez Lopez-Guarch, Maria Teresa Subirana-Domenech, et al.
International Journal of Cardiology|February 13, 2017
Benefits of skeletal-muscle exercise training in pulmonary arterial hypertension: The WHOLEi+12 trialLaura González-Saiz, Carmen Fiuza-Luces, Fabian Sanchis-Gomar, et al.
Open Forum Infectious Diseases|July 14, 2026
Evaluation of Quantitative Differences of Classic Methods, Fungal Biomarkers, and T2Candida for Assessing the Central Venous Catheter Origin of CandidemiaAna Soriano-Martín, Antonio Vena, María Jesús Pérez-Granda, et al.
Pageof 27